Excinuclease

Excinuclease

Excinuclease, also known as excision endonuclease, is a crucial enzyme complex involved in the DNA repair process, specifically in the nucleotide excision repair (NER) pathway. This enzyme is responsible for recognizing and removing bulky DNA lesions, such as those caused by ultraviolet (UV) light-induced pyrimidine dimers and chemical adducts.

Structure and Function

Excinuclease is a multi-subunit enzyme complex that operates by making dual incisions on the damaged DNA strand. In prokaryotes, such as Escherichia coli, the excinuclease is composed of three subunits: UvrA, UvrB, and UvrC. In eukaryotes, the NER pathway involves a more complex set of proteins, including XPA, RPA, TFIIH, XPC, and the ERCC1-XPF and XPG endonucleases.

Prokaryotic Excinuclease

In E. coli, the NER process begins with the UvrA and UvrB proteins forming a complex that scans the DNA for distortions. Upon encountering a lesion, UvrA dissociates, and UvrB remains bound to the DNA. UvrC then binds to the UvrB-DNA complex, and together they make incisions on both sides of the lesion: UvrC cuts the 8th phosphodiester bond 5' to the lesion and the 4th or 5th bond 3' to the lesion. This excises a 12-13 nucleotide-long oligonucleotide containing the damage.

Eukaryotic Excinuclease

In eukaryotes, the process is more intricate. The XPC protein recognizes the DNA damage and recruits the transcription factor IIH (TFIIH) complex, which unwinds the DNA around the lesion. The XPA and RPA proteins stabilize the unwound DNA. The ERCC1-XPF complex makes the 5' incision, while the XPG protein makes the 3' incision, excising a 24-32 nucleotide-long segment.

Biological Significance

Excinuclease activity is vital for maintaining genomic stability. The NER pathway repairs a wide range of DNA lesions, preventing mutations that could lead to cancer and other diseases. Defects in NER components can result in disorders such as xeroderma pigmentosum, which is characterized by extreme sensitivity to sunlight and a high predisposition to skin cancers.

Clinical Implications

Understanding the mechanisms of excinuclease and the NER pathway has significant clinical implications. It provides insights into the development of cancer and the cellular response to DNA-damaging agents used in chemotherapy. Moreover, targeting specific components of the NER pathway could enhance the efficacy of certain cancer treatments by sensitizing tumor cells to DNA damage.

See Also

• DNA repair
• Nucleotide excision repair
• Xeroderma pigmentosum

References

• Sancar, A. (1996). "DNA Excision Repair." Annual Review of Biochemistry, 65, 43-81.
• Wood, R. D., Mitchell, M., Sgouros, J., & Lindahl, T. (2001). "Human DNA repair genes." Science, 291(5507), 1284-1289.